Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) Stock Price, News & Analysis

Company Overview

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. its products portfolio includes topical eye drop drug candidates, including surf-100 and surf-200; surf-300, an oral capsule for treating patients suffering from ocular surface diseases, and ded signs and symptoms; klarity drops to protect and rehabilitate the ocular surface pathology for patients with ded; melt-100, a drug that is administered sublingually for conscious sedation during cataract surgery; may-66 that is used for the treatment of symptoms associated with peyronie's diseas

Key Stats

• Today's Range: $26.31 to $26.34
• 50-Day Range: $25.93 to $27.25
• 52-Week Range: $24.32 to $27.72
• Volume: 1,908 shs
• Average Volume: 4,133 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HROWM Stock Analysis - Frequently Asked Questions

How have HROWM shares performed this year?

Harrow Health, Inc. 11.875% Senior Notes due 2027's stock was trading at $25.80 at the beginning of the year. Since then, HROWM shares have increased by 2.1% and is now trading at $26.34.
View the best growth stocks for 2024 here.

How do I buy shares of Harrow Health, Inc. 11.875% Senior Notes due 2027?

Shares of HROWM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Ex-Dividend for 10/31 Dividend: 10/15/2024
• Dividend Payable: 10/31/2024
• Today: 11/17/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: --
• Industry: -
• Sub-Industry: N/A
• Current Symbol: NASDAQ:HROWM
• CUSIP: N/A
• CIK: 1360214
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: 125
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A